Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rahul Sangani, Andrew Ghio, Stacey Culp, Zalak Patel & Sunil Sharma. (2021) Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1873-1885.
Read now
Read now
Articles from other publishers (11)
Qixin Wang, Isaac Kirubakaran Sundar, Joseph H. Lucas, Jun-Gyu Park, Aitor Nogales, Luis Martinez-Sobrido & Irfan Rahman. (2023) Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization. Nature Communications 14:1.
Crossref
Crossref
Taylor T. Teague, Stephanie R. Payne, Bryan T. Kelly, Timothy M. Dempsey, Rozalina G. McCoy, Lindsey R. Sangaralingham & Andrew H. Limper. (2022) Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis. Respiratory Research 23:1.
Crossref
Crossref
Timothy M. Dempsey, Viengneesee Thao, James P. Moriarty, Bijan J. Borah & Andrew H. Limper. (2022) Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Ping Hu, Lisette Leyton, James S. Hagood & Thomas H. Barker. (2022) Thy-1-Integrin Interactions in cis and Trans Mediate Distinctive Signaling. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Barbara Orzechowska, Kamil Awsiuk, Dawid Wnuk, Joanna Pabijan, Tomasz Stachura, Jerzy Soja, Krzysztof Sładek & Joanna Raczkowska. (2022) Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties. International Journal of Molecular Sciences 23:4, pages 2162.
Crossref
Crossref
Guadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, Jose Antonio Rodriguez-Portal, Jaume Sauleda, Belen Nuñez, Diego Castillo, Myriam Aburto, Karina Portillo, Eva Balcells, Diana Badenes-Bonet, Claudia Valenzuela, Estrella Fernandez-Fabrellas, Teresa González-Budiño, Esteban Cano, Orlando Acosta, Virginia Leiro-Fernández, Ana Romero, Lurdes Planas-Cerezales, Ana Villar, Amalia Moreno, Rosalia Laporta, Vanesa Vicens-Zygmunt, Jessica Shull, Tomàs Franquet, Patricio Luburich & Maria Molina-Molina. (2022) Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. Archivos de Bronconeumología 58:2, pages 135-141.
Crossref
Crossref
Chandrakantsing V. Pardeshi, Sagar R. Pardeshi & Jitendra B. Naik. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
219
258
.
Joanna Raczkowska & Barbara Orzechowska. (2020) Effect of tuned elasticity and chemical modification of substrate on fibrotic and healthy lung fibroblasts. Micron 139, pages 102948.
Crossref
Crossref
Simon Cruwys, Peter Hein, Bob Humphries & Darcey Black. (2020) Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities. Drug Discovery Today 25:12, pages 2277-2283.
Crossref
Crossref
Ying Zhou & Xiujuan Chai. (2019) Protective effect of bicyclol against pulmonary fibrosis via regulation of microRNA‐455‐3p in rats. Journal of Cellular Biochemistry 121:1, pages 651-660.
Crossref
Crossref
Timothy M. Dempsey, Lindsey R. Sangaralingham, Xiaoxi Yao, Darshak Sanghavi, Nilay D. Shah & Andrew H. Limper. (2019) Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 200:2, pages 168-174.
Crossref
Crossref